购物车
- 全部删除
- 您的购物车当前为空
Bucillamine (DE019) 可防止高危器官移植中的缺血/再灌注损伤,抑制 VEGF 的产生。 Bucillamine 是一种具有抗风湿和抗血管生成特性的口服活性巯基供体和抗氧化剂。 Bucillamine 可用于脉络膜新生血管和类风湿性关节炎的研究。
为众多的药物研发团队赋能,
让新药发现更简单!
Bucillamine (DE019) 可防止高危器官移植中的缺血/再灌注损伤,抑制 VEGF 的产生。 Bucillamine 是一种具有抗风湿和抗血管生成特性的口服活性巯基供体和抗氧化剂。 Bucillamine 可用于脉络膜新生血管和类风湿性关节炎的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 147 | 现货 | |
10 mg | ¥ 213 | 现货 | |
25 mg | ¥ 347 | 现货 | |
50 mg | ¥ 573 | 现货 | |
100 mg | ¥ 942 | 现货 | |
200 mg | ¥ 1,390 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 119 | 现货 |
产品描述 | Bucillamine (DE019) protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF. Bucillamine is an orally active sulfhydryl donor and antioxidant with antirheumatic and antiangiogenic properties. Bucillamine can be used for studies about choroidal neovascularization and rheumatoid arthritis. |
体内活性 | In rats subjected to liver transplants, Bucillamine significantly enhances survival and protected against hepatic injury[2]. Subconjunctival injection of Bucillamine significantly reduces the leakage and size of experimental CNV in rats[3]. |
别名 | 布西拉明, Tiobutarit, Thiobutarit, SA96, DE-019, DE019, DE 019 |
分子量 | 223.31 |
分子式 | C7H13NO3S2 |
CAS No. | 65002-17-7 |
Smiles | [C@@H](NC(C(C)(C)S)=O)(C(O)=O)CS |
密度 | 1.289 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 25 mg/mL (111.95 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容